Quick search:
Result Content Outlet Published Research
Result Content Outlet Published Research
1 Tow Foundation Commits $2 Million to Multiple Myeloma Research at Sylvester InventUM | University of Miami Miller School of Medicine 19 days ago
2 A Case of Newly Diagnosed Multiple Myeloma Targeted Oncology 7 days ago
3 Arcellx Announces Dosing of First Patient in its Phase 1 Clinical Trial Evaluating ACLX-001, the First Therapeutic in the Dosable and Controllable ARC-SparX Platform, for the treatment of Patients with Relapsed or Refractory Multiple Myeloma Yahoo Finance 6 days ago
4 New Chief of Bone Marrow Transplant and Cellular Therapies Named to New Jersey’s Only NCI-designated Comprehensive Cancer Center Newswise 25 days ago
5 CAR-T therapy effective in Black and Hispanic patients Science Daily 18 days ago
6 Starton Therapeutics Provides Update on STAR-LLD Lenalidomide Clinical Program GlobeNewswire 12 days ago
7 ORIC Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Update The Bakersfield Californian 7 days ago
8 Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2022 Yahoo Finance 4 days ago
9 Real-World Data Confirm Lack of Standard Care for Triple-Exposed Multiple Myeloma Cancer Therapy Advisor 18 days ago
10 International Myeloma Foundation Welcomes Fatima Scipione as Senior Vice President of Strategic Alliances and External Affairs Yahoo Finance 4 days ago
11 How to manage multiple myeloma pain in the body Medical News Today 25 days ago
12 Cilta-Cel Induces Impressive ORR in Relapsed/Refractory Multiple Myeloma OncLive 13 days ago
13 Medical Minute: OhioHealth Blood and Marrow Transplant Program OhioHealth Newsroom 28 days ago
14 VRd for multiple myeloma: Uses and side effects Medical News Today 20 days ago
15 iTeos Reports First Quarter 2022 Financial Results and Provides Business Update GlobeNewswire 4 days ago
16 Dr. Lin on Treatment Updates in CAR T-Cell Therapy in Myeloma OncLive 25 days ago
17 Roswell Park Specialists to Highlight Latest Advances in Blood Cancer Treatment and Cellular Therapy Newswise 23 days ago
18 Episode 2: Frontline Therapy for Multiple Myeloma Medscape 13 days ago
19 Fresenius Kabi Introduces New Generic for the Treatment of Multiple Myeloma Business Wire 14 days ago
20 Multiple Myeloma is Being Diagnosed More Often in Younger Patients, But The Reasons Why Are Unclear 2 months ago
21 Roche's TIGIT flop prompts GSK, iTeos to reevaluate next steps for rival drug FierceBiotech 3 days ago
22 Caribou Biosciences Reports First Quarter 2022 Financial Results and Provides Business Updates Yahoo Finance 7 days ago
23 Educated Patient® Multiple Myeloma Summit Upcoming FDA Approvals Presentation: March 12, 2022 1 month ago
24 Allogene Therapeutics Receives FDA Orphan-Drug Designation for ALLO-605, its First TurboCAR™ T Cell Product Candidate, for the Treatment of Multiple Myeloma BioSpace 19 days ago
25 UCSF Showcases Potentially Game-Changing Trials Across Multiple Myeloma Settings OncLive 3 months ago
26 ESPN's Dave Flemming Salutes Colleague Rod Gilmore, John Saunders Award Recipient At The Dick Vitale Gala Tonight 10 days ago
27 MiNK Therapeutics Corporate Update and First Quarter 2022 Financial Report Yahoo Finance 6 days ago
28 Ace the Case: A 68-Year-Old Woman With Smoldering Multiple Myeloma Healio 1 month ago
29 Smilow Multiple Myeloma and Gammopathies Program < Yale School of Medicine Yale School of Medicine 1 year ago
30 Moving Mountains for Multiple Myeloma 2 months ago
31 Optimizing Therapy in Frontline Multiple Myeloma Not Eligible for Transplant Cancer Network 5 months ago
32 The Melanoma Research Alliance Names Dr. Marc Hurlbert as Chief Executive Officer Business Wire 4 days ago
33 Moving Mountains for Multiple Myeloma Program to Hike Through Alaska's Kenai Peninsula-Glaciers, Coastline & Wildlife in August 9 months ago
34 Merck To Present Data at 2022 ASCO Annual Meeting Highlighting Promising Pipeline Medicines and Significant Progress in Treating Earlier Stages of Certain Cancers With KEYTRUDA® (pembrolizumab) Merck 6 days ago
35 Dr. Gerald A. 'Jerry' Glowacki, a retired OB-GYN and former department chair at MedStar Franklin Square Medical Center, dies Baltimore Sun 4 days ago
36 Recap: Improving Outcomes in Newly Diagnosed Multiple Myeloma Cancer Network 4 months ago
37 Sutro Biopharma Reports First Quarter 2022 Financial Results, Business Highlights, and Anticipated Milestones GlobeNewswire 7 days ago
38 Multiple myeloma specialist named inaugural director of blood cancer center Healio 3 months ago
39 NCI Cancer Currents Blog: Perlmutter Cancer Center Medical Oncologist Discusses New Treatment for Multiple Myeloma NYU Langone Health 2 months ago
40 Perlmutter Cancer Center Appoints Inaugural Director of Center for Blood Cancers NYU Langone Health 4 months ago
41 Multiple Myeloma Symptoms & Treatment in NJ RWJBarnabas Health 4 months ago
42 CORRECTION Celyad Oncology Announces First Quarter 2022 Financial Results and Recent Business Highlights 11 days ago
43 A Glimpse Into the Future of Myeloma Patient Management Healio 4 months ago
44 Myeloma Research at Dana-Farber Advances With $40M Foundation Givt Myeloma Research News 4 months ago
45 Paying It Forward for Other Patients With Multiple Myeloma 7 months ago
46 Gamida Cell Reports First Quarter 2022 Financial Results and Provides Company Update Business Wire 6 days ago
47 Cellectis Provides Business Update and Reports Financial Results for First Quarter 2022 KULR-TV 4 days ago
48 Multiple Myeloma Landscape Grows At Rapid Pace With Quadruplets and BCMA-Directed Therapy OncLive 3 months ago
49 Survivor on a mission to raise awareness about multiple myeloma, address health disparities Medical University of South Carolina 2 months ago
50 Checkmate details troubled future if Regeneron's $250M buy fails FierceBiotech 3 days ago
51 GSK showcases progress from the DREAMM clinical trial program in multiple myeloma at the 2021 ASH Annual Meeting PR Newswire 6 months ago
52 FDA tags Editas' thalassemia cell therapy an orphan drug as it rounds final bend in race to clinic FierceBiotech 3 days ago
53 Jakubowiak on Future Promise of Cilta-Cel Across Settings in Multiple Myeloma at 2021 ASH Cancer Network 4 months ago
54 How One Woman Used Her Multiple Myeloma Diagnosis to Fuel the Search for a Cure 4 months ago
55 Full Show: Engineered Toxin Bodies Targeting CD38 in Myeloma with Shaji Kumar, MD, Mayo Clinic Myeloma Crowd News 4 months ago
56 A Phase IB Study of Teclistamab with Other Treatments in People with Multiple Myeloma On Cancer 3 months ago
57 BioLineRx Reports First Quarter 2022 Financial Results and Provides Corporate Update USA English 5 days ago
58 Multiple Myeloma Awareness Spectrum News 3 months ago
59 Socioeconomic Gaps Can Lead to Poorer Outcomes in Multiple Myeloma 2 months ago
60 Robert’s Story: CAR T Cell Therapy Offers New Hope for Multiple Myeloma On Cancer 12 months ago
61 Living with multiple myeloma during the era of Covid Palm Beach Post 6 months ago
62 A Phase I/II Study of CFT7455 in People with Non-Hodgkin Lymphoma or Multiple Myeloma On Cancer 4 months ago
63 Backed by Strong Survival, Janssen Submits BLA for Multiple Myeloma Drug BioSpace 5 months ago
64 Multiple Myeloma Chicago Health 2 months ago
65 GSK crowdsources multiple myeloma innovation in new program Medical Marketing and Media 4 months ago
66 The MMRF: Understanding and Sharing the Genomic Landscape of Multiple Myeloma Managed Markets Network 5 months ago
67 First Allogeneic RNA Cell Therapy Clinical Trial Begins in Multiple Myeloma 4 months ago
69 Thomas G. Martin, MD, Discusses Approval of Cilta-Cel in R/R Multiple Myeloma Cancer Network 2 months ago
70 Scientists Identify New Types of a Blood Cancer and Potential Targeted Treatments Mount Sinai 6 months ago
71 Myeloma at MD Anderson: Watch the MCRT in Houston Online on March 26 Myeloma Crowd News 2 months ago
72 Miami Cancer Institute Launches Two FDA-Approved Clinical Trials for Patients with Blood Cancers Who Undergo Stem Cell Transplantation Baptist Health South Florida 2 months ago
73 New Blood Tests Reduce Need for Bone Marrow Biopsy in Multiple Myeloma Targeted Oncology 2 months ago
74 UCSF's Dr Thomas Martin Discusses Quadruplets vs Triplets in Multiple Myeloma Managed Markets Network 7 months ago
75 Takeda previews early response data for 'Wave 2' multiple myeloma med in follow-up to Velcade FierceBiotech 5 months ago
76 CASI Pharmaceuticals, Inc.'s (CASI) CEO Wei-Wu He on Q1 2022 Results Earnings Call Transcript 4 days ago
77 Six Steps for Newly Diagnosed Multiple Myeloma Patients Myeloma Crowd News 2 months ago
78 How Can Multiple Myeloma Affect a Patient's Lifestyle? Cancer Therapy Advisor 2 months ago
79 Treatment With Cilta-Cel Continues Yield Robust, Long-Lasting Outcomes in Relapsed/Refractory Multiple Myeloma Cancer Network 5 months ago
80 Depression and Anxiety Shown to Deter Patients With Cancer From Joining Clinical Trials 2 months ago
81 How Does Multiple Myeloma Affect COVID-19 Vaccines? 2 months ago
82 New Data from MajesTEC-1 Study Show Continued Deep and Durable Responses of Teclistamab (BCMAxCD3 Bispecific Antibody) in Treatment of Heavily Pretreated Patients with Multiple Myeloma PR Newswire 5 months ago
83 Poseida Therapeutics Provides Update on BCMA-Targeted CAR-T Clinical Trials at the 2021 American Society of Hematology (ASH) Annual Meeting Yahoo Finance 5 months ago
84 Precision BioSciences Reports First Quarter 2022 Financial Results and Provides Business Update Business Wire 7 days ago
85 Challenges in Treating Transplant-Ineligible Multiple Myeloma Cancer Network 8 months ago
86 A Phase III Study Comparing JNJ-68284528 CAR T-Cell Therapy with a Combination of Standard Medical Treatments in Patients with Recurrent or Persistent Multiple Myeloma On Cancer 3 months ago
87 Why It's Important to Collaborate Through Communication in Myeloma 2 months ago
88 Feasibility of a Digital Life Coaching Intervention for Patients Undergoing SCT for Multiple Myeloma Oncology Nurse Advisor 4 months ago
89 Legend Biotech to Host Hybrid KOL Event Detailing CARTITUDE Data from the 63rd American Society of Hematology (ASH) Annual Meeting Yahoo Finance 5 months ago
90 ONCONOVA THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) 3 days ago
91 GSK unveils Target the Future, a global, multi-year program to help address key challenges affecting the multiple myeloma community PR Newswire 6 months ago
92 Compugen Presents New Research Suggesting Targeting DNAM-1 Axis Holds Promise for Treatment of Multiple Myeloma Yahoo Finance 2 months ago
93 Clinical Case 1: 69-Year-Old Man With Multiple Myeloma (MM) OncLive 5 months ago
94 CAR-T Cell Therapy May Have 'Big Future' in Relapsed/ Refractory Multiple Myeloma 2 months ago
95 Ace the Case: 71-Year-Old Woman With IgG Lambda Multiple Myeloma at Third Relapse Healio 3 months ago
96 Treating Bone Pain in Multiple Myeloma 2 months ago
97 Sanofi announces €300 million collaboration with Blackstone Life Sciences to advance an innovative treatment for multiple myeloma BioSpace 2 months ago
98 Triplet and Quadruplet Induction Regimens for Transplant-Eligible NDMM: Focus on GRIFFIN and MASTER Trials Cancer Network 2 months ago
99 Molecular Templates, Inc. Reports First Quarter 2022 Financial Results GlobeNewswire 4 days ago
100 Dr. Martin on Key Advances in Multiple Myeloma OncLive 9 months ago